" Blood Feudrivals A Civil Actionfor best non-fiction book of the past twenty years." - John Lescroart, New York Timesbestselling author of Damage Procrit seemed like a biotech miracle, promising a golden age in medical care. Developed in the 1980s by Amgen and licensed to the pharmaceutical giant, Johnson & Johnson, the drug (AKA Epogen and Aranesp) soon generated billions in annual revenue-and still does. Mark Duxbury was a J&J salesman who believed in the blood-booster, setting record sales and winning company awards. Then Duxbury started to learn unsavory truths about Procrit and J&J's business practices. He was fired and filed a whistleblower suit to warn the public. When Jan Schlichtman ( A Civil Action) learned of Duxbury's crusade, he signed on. Now, he's fighting on behalf of cancer patients and for every American who trusts Big Pharma with his life.